Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell and gene therapies and help ensure consistent safety and efficacy ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Every day, hospitals throughout the U.S. transfuse blood or blood components, such as platelets, to save the lives of people ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Right now, there’s no magic drug or treatment that will help reverse your biological age, but doctors universally agree that ...

Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions –– Reflects positive preliminary Phase 2 Safety ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of ...

The FDA has granted Breakthrough Therapy Designation for SkinTE based on key positive data from the Phase II study in Wagner1 DFUs highlighting ...